Ironwood Pharmaceuticals Inc (NAS:IRWD)
$ 4.45 -0.14 (-3.05%) Market Cap: 712.13 Mil Enterprise Value: 1.26 Bil PE Ratio: 0 PB Ratio: 0 GF Score: 54/100

Ironwood Pharmaceuticals Inc Call to Discuss the IW-3718 program Transcript

Sep 29, 2020 / 12:30PM GMT
Release Date Price: $9.42 (-1.15%)
Operator

Ladies and gentlemen, thank you for standing by, and welcome to the Ironwood Conference Call. (Operator Instructions)

I would now like to hand the conference over to your speaker today, Meredith Kaya. You may begin.

Meredith Kaya
Ironwood Pharmaceuticals, Inc. - VP of IR & Corporate Communications

Good morning, and thanks for joining us to discuss our 3718 Phase III program. A press release crossed the wire this morning and can be found on our website, www.ironwoodpharma.com.

Today's call includes forward-looking statements. Such statements involve risks and uncertainties that may cause actual results to differ materially. A discussion of these statements and risk factors is available under the heading Risk Factors in our annual report on Form 10-Q for the quarter ended June 30, 2020, and in our future SEC filings. Our forward-looking statements speak as of today's date, and we undertake no obligation to update such statements.

During this conference call,

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot